Omnicol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is an osmotic polymer that retains water in the intestinal lumen, increasing stool volume and softness. The added electrolytes maintain osmotic equilibrium, allowing effective laxation while minimizing shifts in serum sodium, potassium, and chloride levels.

The specific dose of Omnicol is determined by the prescribing healthcare professional based on the indication, patient age, weight, and clinical condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Omnicol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Omnicol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Omnicol combines macrogol 3350 with electrolytes, offering effective osmotic laxation while helping to maintain electrolyte balance. Compared with sodium‑phosphate preparations, it generally has a lower risk of significant electrolyte disturbances, but individual patient factors and physician preference guide the choice of therapy.

Omnicol should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Ensure the container is tightly closed and keep it out of reach of children.

Omnicol is taken orally as directed by a healthcare professional. The solution is usually measured with a calibrated device and consumed with a glass of water. The exact administration schedule depends on the intended use, such as constipation relief or bowel preparation.

Serious risks include severe dehydration, significant electrolyte imbalances (such as hypernatremia or hyperkalemia), allergic reactions, and, in rare cases, acute renal impairment. Patients should be monitored for these events, especially if they have underlying kidney disease or are taking interacting medications.

Omnicol should be avoided in individuals with known mechanical bowel obstruction, severe renal impairment, uncontrolled electrolyte disorders, or hypersensitivity to any of its components. It should also be used with caution in pregnant or breastfeeding women and in the elderly, under medical supervision.